This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NextGen (NXGN) Reinforces Its Robust Solutions Portfolio
by Zacks Equity Research
NextGen's (NXGN) solid solutions portfolio receives further boost with the success of its Population Health tool.
Baxter's (BAX) Vital Edge Program Aids Patient Blood Management
by Zacks Equity Research
Baxter's (BAX) Vital Edge program enables AdventHealth Tampa to achieve cost savings.
Here's Why You Should Retain LHC Group (LHCG) Stock Now
by Zacks Equity Research
LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.
Here's Why You Should Invest in Cardinal Health (CAH) Stock
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.
Why You Should Add Merit Medical (MMSI) to Your Portfolio
by Zacks Equity Research
Investor confidence is high on Merit Medical (MMSI) stock, courtesy of its solid prospects.
New Strong Buy Stocks for November 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Top Ranked Growth Stocks to Buy for November 30th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, November 30th.
PDCO vs. MMSI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Here's Why You Should Invest in Cardinal Health (CAH) Stock
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
by Zacks Equity Research
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Here's Why You Should Retain McKesson (MCK) Stock for Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet
by Zacks Equity Research
Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet
6 Stocks Near 52-Week Highs Poised to Appreciate Further
by Anirudha Bhagat
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
Here's Why Merit Medical (MMSI) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 2nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 2nd
Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Merit Medical (MMSI) Rallies 4.8% Post Q3 Earnings Beat
by Zacks Equity Research
Merit Medical (MMSI) reported growth in revenues at Cardiovascular segment in the third quarter.
Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Merit Medical (MMSI) delivered earnings and revenue surprises of 121.05% and 11.38%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Luminex (LMNX) Stock for Now
by Zacks Equity Research
Investor confidence is high on Luminex (LMNX) stock, thanks to solid prospects.
Here's Why You Should Avoid Betting on Integer Holdings Now
by Zacks Equity Research
Stiff competition in the MedTech space and weak segmental and operational performance weighs on Integer Holdings (ITGR).
Cerner Inks Deal to Simplify Advance Care Planning Procedure
by Zacks Equity Research
Cerner's (CERN) partners with Vynca to simplify advance care planning process, thereby enabling patients and clinicians to discuss and make critical end-of-life decisions.
Zacks Value Trader Highlights: NortonLifeLock, Advance Auto Parts, Aecom, Green Dot and Merit Medical
by Zacks Equity Research
Zacks Value Trader Highlights: NortonLifeLock, Advance Auto Parts, Aecom, Green Dot and Merit Medical
3 Great MedTech Stocks to Pick Amid the Coronavirus Crisis
by Sriparna Ghosal
Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.
Should Value Investors Buy SPACs?
by Tracey Ryniec
Value hedge fund managers are launching SPACs in 2020 as value investors struggle to keep up with the return on growth stocks.